摘要
目的:研究绿原酸对单纯疱疹病毒I型(HSV-1)的体外抑制作用。方法:采用细胞培养技术,通过绿原酸预处理对病毒的抑制作用、病毒感染细胞同时使用绿原酸和预先使用绿原酸再感染病毒3种给药方法,利用生物显微镜观察幼仓鼠肾细胞(BHK-21)发生病变的情况及观察实验组与病毒对照组病毒感染的滴度。结果:绿原酸在BHK-21细胞上具有明显的抗病毒作用,绿原酸对病毒的最小有效浓度(MIC)为1.0μg.mL-1,而且毒性低,最大无毒浓度(TD0)为200μg.mL-1,其治疗指数(TI)为200;绿原酸浓度1μg.mL-1预处理细胞24h以上能有效抑制病毒感染;绿原酸对HSV-1病毒无直接杀伤作用。结论:绿原酸在体外实验中对HSV-1感染具有明显的抗病毒作用,且能有效预防病毒感染的作用,但对病毒无直接杀死作用。
AIM: To study the antiviral activity and mechanism of Chlorogenic Acid and develop a safe and effective antiviral agent against Herpes Simplex Virus(HSV-1). METHODS: The cytopathic effects (CPE)of CHA on BHK-21 cells was observed. The directly killing effect, inhibitory effect and interdictory effect were tested respectively under the microscope by three ways: drug used directly, drug used while cell were infected and drug used prior to infection. RESULTS: In cell culture, the drug was found to be a inhibitor of HSV-1 in a concentration-dependent manner. The minimal inhibitory concentration (MIC) was 1 μg·mL^-1, the maximal innocuous dose (TD0) was 200 μg·mL^-1, and the treatment index (TI) was 200. The CHA showed remarkable inhibitory effects on HSV-1. Also, CHA showed significant interdictory effects on virus infection pretreated with CHA above the concentration 1 μg·mL^-1; CHA have no effective on killing Virus directly. CONCLUSION: CHA has antiviral activity on HSV-1 in vitro, and remarkable prevent virus infection, but have no directly killing effect.
出处
《中国天然药物》
SCIE
CAS
CSCD
2008年第3期232-234,共3页
基金
国家科技部支撑计划(No2006BAI14B05)~~